» Articles » PMID: 26742632

Age-related Macular Degeneration: Complement in Action

Overview
Journal Immunobiology
Publisher Elsevier
Date 2016 Jan 9
PMID 26742632
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The complement system plays a key role in host-defense against common pathogens but must be tightly controlled to avoid inflammation and tissue damage. Polymorphisms in genes encoding two important negative regulators of the alternative complement pathway, complement factor H (CFH) and complement factor I (CFI), are associated with the risk for Age-Related Macular Degeneration (AMD), a leading cause of vision impairment in the ageing population. In this review, we will discuss the genetic basis of AMD and the potential impact of complement de-regulation on disease pathogenesis. Finally, we will highlight recent therapeutic approaches aimed at controlling complement activation in patients with AMD.

Citing Articles

Fish Models of Ageing Retinal Disease.

Noel N Adv Exp Med Biol. 2025; 1468:225-228.

PMID: 39930200 DOI: 10.1007/978-3-031-76550-6_37.


The Complement System as a Therapeutic Target in Retinal Disease.

Ong J, Zarnegar A, Selvam A, Driban M, Chhablani J Medicina (Kaunas). 2024; 60(6).

PMID: 38929562 PMC: 11205777. DOI: 10.3390/medicina60060945.


Pre-Clinical Studies of a Novel Bispecific Fusion Protein Targeting C3b and VEGF in Neovascular and Nonexudative AMD Models.

Lee Y, Kim D, Chung P, Lee M, Kim N, Chang J Ophthalmol Ther. 2024; 13(8):2227-2242.

PMID: 38907092 PMC: 11246403. DOI: 10.1007/s40123-024-00982-3.


Current Views on Chr10q26 Contribution to Age-Related Macular Degeneration.

Gogna N, Hyde L, Collin G, Stone L, Naggert J, Nishina P Adv Exp Med Biol. 2023; 1415:27-36.

PMID: 37440010 DOI: 10.1007/978-3-031-27681-1_5.


Screening for biomarkers in age-related macular degeneration.

Han D, He X Heliyon. 2023; 9(7):e16981.

PMID: 37415944 PMC: 10320320. DOI: 10.1016/j.heliyon.2023.e16981.